Breaking News Instant updates and real-time market news.

2020-03-17 10:45:00 10:45 03/17/20 03/17 10:45 03/17/20 10:45	8-Week Bill Announcement to be released at 11:00

TODAY'S FREE FLY STORIES

Earnings	Reliant Bancorp reports Q4 EPS 73c, consensus 53c » 17:00 01/21/21 01/21 17:00 01/21/21 17:00 RBNC Reliant Bancorp $19.57 / -0.34 (-1.71%) DeVan Ard Jr., Reliant… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events RBNC Reliant Bancorp $19.57 / -0.34 (-1.71%) 09/21/20 Reliant Bancorp CAO Kowalski resigns RBNC Reliant Bancorp $19.57 / -0.34 (-1.71%) 06/09/20 Raymond James Reliant Bancorp initiated with a Market Perform at Raymond James 04/30/20 Janney Montgomery Scott Reliant Bancorp upgraded to Buy on better margins at Janney Montgomery Scott 04/30/20 Janney Montgomery Scott Reliant Bancorp upgraded to Buy from Neutral at Janney Montgomery Scott 04/06/20 Piper Sandler Reliant Bancorp upgraded to Overweight from Neutral at Piper Sandler RBNC Reliant Bancorp $19.57 / -0.34 (-1.71%) 10/22/20 Reliant Bancorp reports Q3 EPS 69c, consensus 46c 07/23/20 Reliant Bancorp says company 'well positioned' heading into 2H20 07/23/20 Reliant Bancorp reports Q2 EPS 48c, consensus 28c 01/22/21 Reliant Bancorp - RBNC
Hot Stocks	Apache Q4 estimated average U.S. oil price $41BBL » 16:58 01/21/21 01/21 16:58 01/21/21 16:58 APA Apache $16.65 / -0.795 (-4.56%) Apache provided… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events Options APA Apache $16.65 / -0.795 (-4.56%) 01/14/21 Apache announces fourth oil discovery at Keskesi East-1 Well 01/04/21 Apache announces creation of holding company structure 09/23/20 Archer gets contract for platform drilling with Apache in North Sea 09/14/20 Apache provides update on Kwaskwasi-1 Discovery well offshore Suriname APA Apache $16.65 / -0.795 (-4.56%) 01/15/21 Citi Apache price target raised to $21 from $16 at Citi 01/14/21 Barclays Apache upgraded to Overweight with $20 target at Barclays 01/14/21 Barclays Apache upgraded to Overweight from Equal Weight at Barclays 01/14/21 Truist Apache upgraded to Buy from Hold at Truist APA Apache $16.65 / -0.795 (-4.56%) 11/04/20 Apache reduces FY20 upstream capital guidance to $1B 11/04/20 Apache reports Q3 EPS (16c), consensus (35c) 07/29/20 Apache reports Q2 adjusted EPS (74c), consensus ($1.01) APA Apache $16.65 / -0.795 (-4.56%) 07/29/20 Fly Intel: After-Hours Movers 03/01/21 26th Annual Energy Virtual Summit APA Apache $16.65 / -0.795 (-4.56%) 01/14/21 Early notable gainers among liquid option names on January 14th 01/05/21 Unusually active option classes on open January 5th 12/11/20 Apache call volume above normal and directionally bullish 12/10/20 Apache call volume above normal and directionally bullish
Hot Stocks	Seagate says 2020 'a very challenging year' » 16:53 01/21/21 01/21 16:53 01/21/21 16:53 STX Seagate $63.00 / +1.57 (+2.56%) Sees demand for max… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events Options STX Seagate $63.00 / +1.57 (+2.56%) 01/19/21 Nidec files patent infringement suit against Seagate 12/28/20 Seagate appoints Prat Bhatt to Board of Directors 12/16/20 Intel announces next generation of memory and storage products 11/05/20 Climb Channel Solutions adds Seagate data storage systems to distribution line STX Seagate $63.00 / +1.57 (+2.56%) 07:08 Today Barclays Seagate price target raised to $60 from $41 at Barclays 01/20/21 Wedbush Seagate price target raised to $56 from $47 at Wedbush 01/19/21 Northland Seagate price target raised to $72 from $65 at Northland 01/19/21 Loop Capital Seagate price target raised to $70 from $60 at Loop Capital STX Seagate $63.00 / +1.57 (+2.56%) 16:06 Today Seagate sees Q3 adjusted EPS $1.30, plus/minus 15c, consensus $1.26 16:05 Today Seagate reports Q2 adjusted EPS $1.29, consensus $1.13 10/22/20 Seagate sees Q2 adjusted EPS $1.10, plus/minus 15c, consensus $1.08 10/22/20 Seagate reports Q1 adjusted EPS 93c, consensus 88c STX Seagate $63.00 / +1.57 (+2.56%) 12/28/20 Kinnate initiations, Nikola target change among today's top calls on Wall Street 10/23/20 Fly Intel: Wall Street's top stories for Friday 10/23/20 Fly Intel: Wall Street's top stories at midday 10/23/20 Fly Intel: Pre-market Movers 16:30 Today Seagate - STX STX Seagate $63.00 / +1.57 (+2.56%) 15:34 Today Seagate options imply 7.9% move in share price post-earnings 12/28/20 Largest borrow rate increases among liquid names 12/21/20 Seagate call volume above normal and directionally bullish 12/01/20 Seagate call volume above normal and directionally bullish
Hot Stocks	Consolidated Edison raises quarterly dividend to 77.5c from 76.5c per share » 16:51 01/21/21 01/21 16:51 01/21/21 16:51 ED Consolidated Edison $69.16 / -0.78 (-1.12%) The dividend is payable… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Options ED Consolidated Edison $69.16 / -0.78 (-1.12%) 10/05/20 Itron, Con Ed confirm, NYS affirmed its consent approval for Itron ERT module 09/17/20 Consolidated Edison CEO John McAvoy to retire, Tim Cawley to succeed in 2021 08/13/20 NY PSC announces $10.75M settlement with Con Edison ED Consolidated Edison $69.16 / -0.78 (-1.12%) 08:34 Today Evercore ISI Consolidated Edison downgraded to Underperform from In Line at Evercore ISI 11/18/20 Barclays Consolidated Edison price target raised to $83 from $74 at Barclays 11/12/20 Mizuho Consolidated Edison price target raised to $83 from $72 at Mizuho 10/19/20 Goldman Sachs Consolidated Edison downgraded to Sell from Neutral at Goldman Sachs ED Consolidated Edison $69.16 / -0.78 (-1.12%) 16:50 Today Consolidated Edison sees FY20 EPS at low end of prior $4.15-$4.30 target range 11/05/20 Consolidated Edison narrows FY20 adj. EPS view to $4.15-$4.30 from $4.15-$4.35 11/05/20 Consolidated Edison reports Q3 adjusted EPS $1.48, consensus $1.50 11/05/20 Notable companies reporting after market close 02 Dec ED Consolidated Edison $69.16 / -0.78 (-1.12%) 09/25/20 Cruise Line upgrades among today's top calls on Wall Street ED Consolidated Edison $69.16 / -0.78 (-1.12%) 09/17/20 Consolidated Edison call volume above normal and directionally bullish
Earnings	Consolidated Edison sees FY20 EPS at low end of prior $4.15-$4.30 target range » 16:50 01/21/21 01/21 16:50 01/21/21 16:50 ED Consolidated Edison $69.16 / -0.78 (-1.12%) Consensus $4.22. The… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Options ED Consolidated Edison $69.16 / -0.78 (-1.12%) 10/05/20 Itron, Con Ed confirm, NYS affirmed its consent approval for Itron ERT module 09/17/20 Consolidated Edison CEO John McAvoy to retire, Tim Cawley to succeed in 2021 08/13/20 NY PSC announces $10.75M settlement with Con Edison ED Consolidated Edison $69.16 / -0.78 (-1.12%) 08:34 Today Evercore ISI Consolidated Edison downgraded to Underperform from In Line at Evercore ISI 11/18/20 Barclays Consolidated Edison price target raised to $83 from $74 at Barclays 11/12/20 Mizuho Consolidated Edison price target raised to $83 from $72 at Mizuho 10/19/20 Goldman Sachs Consolidated Edison downgraded to Sell from Neutral at Goldman Sachs ED Consolidated Edison $69.16 / -0.78 (-1.12%) 11/05/20 Consolidated Edison narrows FY20 adj. EPS view to $4.15-$4.30 from $4.15-$4.35 11/05/20 Consolidated Edison reports Q3 adjusted EPS $1.48, consensus $1.50 11/05/20 Notable companies reporting after market close 08/06/20 Consolidated Edison backs FY20 adjusted EPS view $4.15-$4.35, consensus $4.25 02 Dec ED Consolidated Edison $69.16 / -0.78 (-1.12%) 09/25/20 Cruise Line upgrades among today's top calls on Wall Street ED Consolidated Edison $69.16 / -0.78 (-1.12%) 09/17/20 Consolidated Edison call volume above normal and directionally bullish

Hot Stocks	Enterprise Products, Magellan Midstream to develop Houston crude oil futures » 16:49 01/21/21 01/21 16:49 01/21/21 16:49 EPD Enterprise Products $22.42 / -0.63 (-2.73%) , MMP Magellan Midstream $46.28 / + (+0.00%) Magellan Midstream (MMP)… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events Options EPD EPD Enterprise Products $22.42 / -0.63 (-2.73%) 09/09/20 Enterprise Products cancelling Echo 4 pipeline project 07/29/20 Enterprise Products expects 2020 growth CapEx $2.5B-$3.0B EPD MMP EPD Enterprise Products $22.42 / -0.63 (-2.73%) 01/20/21 Mizuho Enterprise Products price target raised to $27 from $24 at Mizuho 12/03/20 SMBC Nikko Enterprise Products initiated with an Outperform at SMBC Nikko 11/23/20 Wolfe Research Enterprise Products upgraded to Outperform from Peer Perform at Wolfe Research 11/13/20 Evercore ISI Enterprise Products upgraded to Outperform from In Line at Evercore ISI MMP Magellan Midstream $46.28 / + (+0.00%) 01/20/21 Mizuho Magellan Midstream price target raised to $49 from $45 at Mizuho 01/06/21 BofA Magellan Midstream downgraded to Neutral from Buy at BofA 01/06/21 BofA Magellan Midstream downgraded to Neutral from Buy at BofA 12/17/20 Credit Suisse Magellan Midstream downgraded to Neutral from Outperform at Credit Suisse EPD MMP EPD Enterprise Products $22.42 / -0.63 (-2.73%) 10/28/20 Enterprise Products reports Q3 EPS 48c, consensus 48c 07/29/20 Enterprise Products reports Q2 EPS 47c, consensus 48c MMP Magellan Midstream $46.28 / + (+0.00%) 10/30/20 Magellan Midstream sees FY20 EPS $3.60, consensus $3.63 10/30/20 Magellan Midstream reports Q3 non-GAAP EPS 97c, consensus 84c 07/30/20 Magellan Midstream sees Q3 75c-85c, consensus 86c 07/30/20 Magellan Midstream narrows 2020 EPS view to $3.50-$3.70 from $3.35-$3.70 02/02/21 Magellan Midstream - MMP 02/22/21 Enterprise Products Partners L.P. 02/23/21 Enterprise Products Partners L.P. 02/23/21 Enterprise Products Partners L.P. EPD EPD Enterprise Products $22.42 / -0.63 (-2.73%) 12/23/20 Largest borrow rate increases among liquid names 11/18/20 Enterprise Products call volume above normal and directionally bullish 11/13/20 Enterprise Products call volume above normal and directionally bullish 11/11/20 Unusually active option classes on open November 11th
Initiation	Raymond James starts Fisker with Market Perform given 'crowded space' » 16:48 01/21/21 01/21 16:48 01/21/21 16:48 FSR Fisker $15.00 / +0.235 (+1.59%) Raymond James analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research On The Fly Events Options FSR Fisker $15.00 / +0.235 (+1.59%) 01/04/21 Magna to collaborate with Fisker on Advanced Driver Assistance System 12/17/20 Fisker jumps with paid Ocean SUV reservations topping 10,400 globally 12/17/20 Fisker, Magna enter definitive platform, manufacturing agreements 12/10/20 Fisker falls -7.4% FSR Fisker $15.00 / +0.235 (+1.59%) 16:33 Today Raymond James Fisker initiated with a Market Perform at Raymond James 01/04/21 Fly Intel: Top five analyst initiations 01/04/21 Vertical Group Fisker initiated with a Buy at Vertical Group 12/30/20 Cowen Fisker estimates reduced following company guidance, says Cowen FSR Fisker $15.00 / +0.235 (+1.59%) 11/25/20 Fly Intel: Wall Street's top stories for Wednesday 11/25/20 Fly Intel: Wall Street's top stories at midday 11/25/20 Ford, Gap downgrades among today's top calls on Wall Street 11/25/20 Fly Intel: Pre-market Movers 02/11/21 Technology & Internet Virtual Conference FSR Fisker $15.00 / +0.235 (+1.59%) 11:25 Today Fisker call volume above normal and directionally bullish 12/31/20 Largest borrow rate increases among liquid names 12/23/20 Fisker call volume above normal and directionally bullish 12/22/20 Largest borrow rate increases among liquid names
Earnings	Boston Private Financial reports Q4 operating EPS 30c, consensus 17c » 16:47 01/21/21 01/21 16:47 01/21/21 16:47 BPFH Boston Private Financial $12.61 / -0.37 (-2.85%) "Fourth quarter 2020… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly BPFH Boston Private Financial $12.61 / -0.37 (-2.85%) 01/05/21 HoldCo expresses concerns regarding Boston Private Financial, SVB Financial deal 01/04/21 Boston Private Financial jumps 21% to $10.15 after resumption of trade 01/04/21 Boston Private Financial trading resumes 01/04/21 Boston Private Financial to resume trading at 17:00ET BPFH Boston Private Financial $12.61 / -0.37 (-2.85%) 01/08/21 Oppenheimer Oppenheimer calls SVB Financial acquisition of Boston Private a 'good move' 01/05/21 DA Davidson SVB Financial price target raised to $400 from $365 at DA Davidson 01/05/21 Raymond James SVB Financial price target raised to $440 from $325 at Raymond James 01/05/21 RBC Capital SVB Financial price target raised to $437 from $320 at RBC Capital BPFH Boston Private Financial $12.61 / -0.37 (-2.85%) 10/21/20 Boston Private Financial reports Q3 ops EPS 27c, consensus 16c 07/28/20 Boston Private Financial reports Q2 EPS (4c), consensus 6c BPFH Boston Private Financial $12.61 / -0.37 (-2.85%) 01/05/21 Fly Intel: Wall Street's top stories for Tuesday 01/05/21 Fly Intel: Wall Street's top stories at midday 01/05/21 Fly Intel: Pre-market Movers 01/04/21 Fly Intel: After-Hours Movers
Hot Stocks	ViiV Healthcare announces FDA approval of Cabenuva » 16:46 01/21/21 01/21 16:46 01/21/21 16:46 GSK GlaxoSmithKline $37.79 / -0.23 (-0.60%) , PFE Pfizer $36.49 / +0.01 (+0.03%) , JNJ Johnson & Johnson $161.69 / -0.71 (-0.44%) ViiV Healthcare, the… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options GSK PFE JNJ GSK GlaxoSmithKline $37.79 / -0.23 (-0.60%) 07:16 Today BiondVax names Amir Reichman as new CEO 01/12/21 Vir Biotechnology, GlaxoSmithKline to evaluate VIR-7832 in COVID-19 patients 01/11/21 Eligo Bioscience enters research, option agreement with GlaxoSmithKline 12/21/20 Ligand, GSK in pact 'leveraging' Icagen's small molecule 'expertise' PFE Pfizer $36.49 / +0.01 (+0.03%) 07:09 Today Cerevel Therapeutics appoints Deval Patrick, Deborah Baron to board 01/20/21 Pfizer, BioNTech: COVID-19 vaccine elicits antibodies neutralizing pseudovirus 01/14/21 Pfizer says FDA approves supplemental NDA for Xalkori 01/14/21 Oragenics issues letter to stockholders on Terra CoV-2 JNJ Johnson & Johnson $161.69 / -0.71 (-0.44%) 05:33 Today Addex Therapeutics receives IND approval to start study in epilepsy 01/19/21 Royalty Pharma acquires royalty interest in Seltorexant from Minerva 01/19/21 Minerva, Royalty Pharma announce sale of seltorexant royalty for up to $155M 01/15/21 Halozyme says Janssen receives FDA approval of Darzalex Faspro GSK PFE JNJ GSK GlaxoSmithKline $37.79 / -0.23 (-0.60%) 01/20/21 UBS GlaxoSmithKline price target raised to 1,450 GBp from 1,440 GBp at UBS 01/20/21 Fly Intel: Top five analyst downgrades 01/20/21 Credit Suisse GlaxoSmithKline downgraded to Underperform from Neutral at Credit Suisse 01/20/21 Credit Suisse GlaxoSmithKline downgraded to Underperform from Neutral at Credit Suisse PFE Pfizer $36.49 / +0.01 (+0.03%) 01/14/21 Morgan Stanley 80%+ efficacy from J&J vaccine would be 'compelling,' says Morgan Stanley 01/14/21 Oppenheimer Essa Pharma price target raised to $20 from $9 at Oppenheimer 01/05/21 Argus Viatris initiated with a Hold at Argus 12/31/20 Ladenburg UK study supports potential of Arcturus COVID vaccine candidate, says Ladenburg JNJ Johnson & Johnson $161.69 / -0.71 (-0.44%) 01/15/21 B. Riley Securities Arcturus Therapeutics downgraded to Neutral from Buy at B. Riley Securities 01/14/21 Morgan Stanley 80%+ efficacy from J&J vaccine would be 'compelling,' says Morgan Stanley 01/14/21 Oppenheimer Essa Pharma price target raised to $20 from $9 at Oppenheimer 12/29/20 Piper Sandler Piper still believes in Arcturus vaccine after 'underwhelming' immunogenicity GSK PFE JNJ GSK GlaxoSmithKline $37.79 / -0.23 (-0.60%) 10/28/20 GlaxoSmithKline now sees 2020 adjusted EPS at lower end of down 1%-4% range 10/28/20 GlaxoSmithKline reports Q3 adjusted EPS 35.6p vs. 38.6p a year ago 10/08/20 GlaxoSmithKline sees impact of foreign exchange on Q3 sales of about 5% 07/29/20 GlaxoSmithKline reports Q2 adjusted EPS 19.2p, down 37% AER PFE Pfizer $36.49 / +0.01 (+0.03%) 01/12/21 Pfizer sees FY21 EPS around $3.00-$3.10, consensus $3.07 10/27/20 Pfizer sees FY20 Upjohn revenue $8B-$8.5B, adjusted EBITDA $3.8B-$4.2B 10/27/20 Pfizer sees FY20 adjusted EPS for New Pfizer $2.28-$2.38, revenue $40.8B-$42.4B 10/27/20 Pfizer narrows FY20 adjusted EPS view to $2.88-$2.93 from $2.85-$2.95 JNJ Johnson & Johnson $161.69 / -0.71 (-0.44%) 10/13/20 Johnson & Johnson sees 'robutst, double-digit sales growth' in 2021 10/13/20 Johnson & Johnson sees Q4 sales 'around' 2019 levels, consensus $21.52B 10/13/20 Johnson & Johnson raises FY20 adj. EPS view to $7.95-$8.05 from $7.75-$7.95 10/13/20 Johnson & Johnson reports Q3 adj. EPS $2.20, consensus $1.98 GSK PFE JNJ GSK GlaxoSmithKline $37.79 / -0.23 (-0.60%) 01/12/21 GSK looks to double blockbusters in portfolio by 2026, Bloomberg says 12/31/20 Drugmakers to hike U.S. prices on over 200 drugs, Reuters reports 12/23/20 Judge rules against White House drug pricing rule, Reuters says 12/11/20 GlaxoSmithKline offered $120 per share for Eidos Therapeutics, Bloomberg says PFE Pfizer $36.49 / +0.01 (+0.03%) 15:21 Today Pfizer slashes vaccine deliveries to some EU countries by 50%, Reuters reports 14:52 Today Pfizer and BioNTech agree to supply vaccine to WHO co-led effort, Reuters says 01/20/21 Hong Kong set to approve COVID vaccine by Pfizer/BioNTech, SCMP says 01/20/21 Japan inks deal with Pfizer for COVID vaccine for 72M people, Nikkei reports JNJ Johnson & Johnson $161.69 / -0.71 (-0.44%) 01/13/21 Johnson & Johnson's one-dose COVID-19 vaccine appears 'promising,' CNBC says 01/13/21 J&J chief science officer sees possible vaccine approval by March, Reuters says 01/13/21 J&J sees U.S. decision on COVID-19 vaccine candidate by March, Bloomberg says 01/13/21 EU lawmaker says J&J likely to submit vaccine approval in Feb., Reuters reports GSK PFE JNJ GSK GlaxoSmithKline $37.79 / -0.23 (-0.60%) 12/31/20 Fly Intel: Wall Street's top stories for Thursday 12/26/20 Week in review: How Trump's policies moved stocks 12/11/20 Fly Intel: Wall Street's top stories for Friday 12/11/20 Fly Intel: Wall Street's top stories at midday PFE Pfizer $36.49 / +0.01 (+0.03%) 01/12/21 Fly Intel: Wall Street's top stories for Tuesday 01/12/21 Fly Intel: Wall Street's top stories at midday 01/08/21 Fly Intel: Wall Street's top stories for Friday 01/08/21 Fly Intel: Wall Street's top stories at midday JNJ Johnson & Johnson $161.69 / -0.71 (-0.44%) 01/14/21 Fly Intel: Wall Street's top stories for Thursday 01/14/21 Fly Intel: Wall Street's top stories at midday 01/13/21 Fly Intel: Wall Street's top stories for Wednesday 12/29/20 Street Fight: Citi sees opportunity in Arcturus as COVID data prompts downgrades 14:00 Today Healthcare 02/08/21 17th Annual Virtual WORLDSymposium 2021 03/02/21 2021 London Global Healthcare Virtual Conference 01/26/21 Johnson & Johnson - JNJ 02/02/21 Pfizer - PFE 02/03/21 GlaxoSmithKline - GSK 01/24/21 PDUFA Date for Xalkori (Crizotinib) - January 2021 12/29/21 PDUFA Date for Lorbrena (Lorlatinib) April 2021 GSK PFE JNJ GSK GlaxoSmithKline $37.79 / -0.23 (-0.60%) 09/04/20 GlaxoSmithKline call volume above normal and directionally bullish 08/03/20 Unusually active option classes on open August 3rd 07/31/20 Unusually active option classes on open July 31st PFE Pfizer $36.49 / +0.01 (+0.03%) 12/15/20 Notable open interest changes for December 15th 12/14/20 Unusually active option classes on open December 14th 12/11/20 Unusually active option classes on open December 11th 12/11/20 Notable open interest changes for December 11th JNJ Johnson & Johnson $161.69 / -0.71 (-0.44%) 12/01/20 Johnson & Johnson call volume above normal and directionally bullish 10/13/20 Unusually active option classes on open October 13th 09/23/20 Unusually active option classes on open September 23rd 08/24/20 Unusually active option classes on open August 24th
Earnings	Bryn Mawr Bank reports Q4 core EPS 77c, consensus 60c » 16:46 01/21/21 01/21 16:46 01/21/21 16:46 BMTC Bryn Mawr Bank $33.21 / -0.72 (-2.12%) "We are pleased with… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research Earnings Events BMTC Bryn Mawr Bank $33.21 / -0.72 (-2.12%) 01/19/21 Stephens Bryn Mawr Bank upgraded to Overweight with $40 price target at Stephens 01/19/21 Stephens Bryn Mawr Bank upgraded to Overweight from Equal Weight at Stephens 12/16/20 Boenning & Scattergood Bryn Mawr Bank upgraded to Outperform from Neutral at Boenning & Scattergood 06/01/20 Stephens Bryn Mawr Bank initiated with an Equal Weight at Stephens BMTC Bryn Mawr Bank $33.21 / -0.72 (-2.12%) 10/22/20 Bryn Mawr Bank reports Q3 core EPS 77c, consensus 61c 01/22/21 Bryn Mawr Bank - BMTC

Hot Stocks	Ford sees 2020 underfunded status for pension of about $6.7B » 16:44 01/21/21 01/21 16:44 01/21/21 16:44 F Ford $11.53 / +0.665 (+6.12%) The company states in an… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options F Ford $11.53 / +0.665 (+6.12%) 16:40 Today Ford to replace Takata airbag inflators in certain models at cost of $610M 01/19/21 EU passenger car registrations down 3.3% in December 01/11/21 Ford to stop manufacturing in Brazil, sees pre-tax special item charges of $4.1B 01/11/21 Ford to stop manufacturing in Brazil, sees pre-tax special item charges of $4.1B F Ford $11.53 / +0.665 (+6.12%) 01/20/21 Deutsche Bank Ford price target raised to $11 from $9 at Deutsche Bank 01/20/21 Deutsche Bank Ford named 'Catalyst Call: Buy Idea' at Deutsche Bank 01/05/21 Benchmark GM, Roku, Marcus among Benchmark's Best Ideas for first half of 2021 12/23/20 Morgan Stanley Apple's potential EV entry represents 'new Tesla bear case,' says Morgan Stanley F Ford $11.53 / +0.665 (+6.12%) 10/28/20 Ford sees temporarily lower F-150 wholesale shipments in Q4 10/28/20 Ford reports Q3 adjusted EBIT $3.6B 10/28/20 Ford reports Q3 adjusted EPS 65c, consensus 16c 10/28/20 Notable companies reporting after market close F Ford $11.53 / +0.665 (+6.12%) 01/19/21 Amazon and Ford backed EV Truck-maker Rivian raises another $2.65B, WSJ says 01/08/21 Ford to idle Kentucky plant, blames microchip shortage, Detroit News reports 01/05/21 Rivian close to raising funds at $25B valuation, Bloomberg says 01/05/21 Rivian close to raising funds at $25B valuation, Bloomberg says F Ford $11.53 / +0.665 (+6.12%) 01/11/21 Fly Intel: Wall Street's top stories for Monday 12/26/20 Charged: Apple's potential EV entry seen as 'Tesla bear case' 12/22/20 Apple rises as Wall Street digests report of self-driving car plans 12/07/20 Fly Intel: Wall Street's top stories for Monday 02/04/21 Ford - F F Ford $11.53 / +0.665 (+6.12%) 11:30 Today Ford call volume off to the races as shares and implied volatility surge 08:55 Today Notable open interest changes for January 21st 01/20/21 Ford call volume above normal and directionally bullish 01/20/21 Early notable gainers among liquid option names on January 20th
Syndicate	Global Partners files $500M mixed securities shelf 16:42 01/21/21 01/21 16:42 01/21/21 16:42 GLP Global Partners $18.72 / +0.39 (+2.13%) ShowHide Related Items >><< Company News Street Research Earnings GLP Global Partners $18.72 / +0.39 (+2.13%) 12/14/20 Global Partners buys retail fuel, convenience stores from Consumers Petroleum 10/26/20 Global Partners boosts quarterly dividend to 50c per share GLP Global Partners $18.72 / +0.39 (+2.13%) 03/24/20 Barclays Global Partners upgraded to Equal Weight from Underweight at Barclays 01/29/20 JPMorgan JPMorgan downgrades four MLPs to Underweight from Neutral 01/29/20 JPMorgan Global Partners downgraded to Underweight from Neutral at JPMorgan GLP Global Partners $18.72 / +0.39 (+2.13%) 11/05/20 Global Partners reports Q3 EPS 47c, consensus 11c 08/06/20 Global Partners reports Q2 EPS $2.17 vs. 36c last year
On The Fly	Fly Intel: Wall Street's top stories for Thursday » 16:40 01/21/21 01/21 16:40 01/21/21 16:40 UAL United Airlines $42.59 / -2.59 (-5.73%) , TRV Travelers $148.81 / +3.73 (+2.57%) , LLY Eli Lilly $202.26 / +0.915 (+0.45%) , ABCL AbCellera $50.91 / +2.68 (+5.56%) , CTVA Corteva $41.65 / -2.02 (-4.63%) , CLGX CoreLogic $76.78 / +1.07 (+1.41%) , CSGP CoStar Group $913.01 / +12.01 (+1.33%) , DBD Diebold $13.05 / +1.85 (+16.52%) , TAL TAL Education $78.02 / +10.29 (+15.19%) , UAA Under Armour $18.69 / +0.08 (+0.43%) , UA Under Armour $16.11 / +0.135 (+0.85%) , DYN Dyne Therapeutics $21.24 / -7.65 (-26.48%) , INMB INmune Bio $20.45 / -4.64 (-18.49%) Stocks on Wall Street… Open Full Text ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events Options UAL TRV LLY ABCL CTVA CLGX CSGP DBD TAL UAA UA DYN INMB UAL United Airlines $42.59 / -2.59 (-5.73%) 10:56 Today United expects international profits to turn more quickly than domestic 10:42 Today United says EBITDA margins should exceed 2019 levels by 2023 01/20/21 United Airlines reports Q4 total passengers down 63.2% y/y 01/05/21 CEO says XpresSpa adding more airport, airlines on-site COVID test locations TRV Travelers $148.81 / +3.73 (+2.57%) 07:09 Today Travelers reports Q4 consolidated combined ratio of 86.7% 06:58 Today Travelers reports book value per share of $115.68, up 14% from year-end 2019 12/03/20 Travelers acquires InsuraMatch from Plymouth Rock Group, terms not disclosed 10/20/20 Travelers CEO says net written premiums in Q3 up nearly 3% LLY Eli Lilly $202.26 / +0.915 (+0.45%) 08:31 Today AbCellera-discovered antibody prevented COVID-19 in nursing homes, reduced risks 08:05 Today Eli Lilly: LY-CoV555 prevented Covid-19 at nursing homes in Blaze-2 trial 01/19/21 Eli Lilly, Merus collaborate for novel T-cell re-directing bispecific antibodies 01/15/21 Eli Lilly reports $30M limited partner investment in Unseen Capital Health Fund ABCL AbCellera $50.91 / +2.68 (+5.56%) 08:31 Today AbCellera-discovered antibody prevented COVID-19 in nursing homes, reduced risks 01/19/21 AbCellera granted U.S. patent covering Trianni Mouse technology 12/28/20 AbCellera rises 1.5% after 5.3% stake disclosed by Peter Thiel in 13D filing 12/21/20 AbCellera announces bamlanivimab to be evaluated in study for COVID-19 patients CTVA Corteva $41.65 / -2.02 (-4.63%) 12:52 Today Corteva confirms receipt of Starboard's intent to nominate directors 07:43 Today Starboard confirms nomination of eight candidates to Corteva's board 01/19/21 Matrix Service subsidiary awarded construction of water facility by Corteva 01/04/21 Corteva welcomes new Chief Technology Officer Sam Eathington CLGX CoreLogic $76.78 / +1.07 (+1.41%) 12/11/20 CoreLogic expects final bids for company in early 2021 11/24/20 CoreLogic board 'fully supportive' of 'robust' sale process 11/23/20 Cannae, Senator ask CoreLogic to set board vote record date 11/17/20 CoreLogic shareholders elect Senator, Cannae nominees to board CSGP CoStar Group $913.01 / +12.01 (+1.33%) 12/29/20 Apartments.com Network acheives 1B website visits in 2020 12/18/20 CoStar Group acquires Houses.com 12/17/20 CoStar Group receives FTC clearance to close acquisition of Homesnap 11/30/20 FTC sues to block CoStar Group's proposed acquisition of RentPath DBD Diebold $13.05 / +1.85 (+16.52%) 10:00 Today Diebold rises 18.2% 09:47 Today Diebold rises 13.8% 09/30/20 Co-op expands partnership with Diebold TAL TAL Education $78.02 / +10.29 (+15.19%) 12:00 Today TAL Education rises 13.8% 12/28/20 TAL Education announces $3.3B private placement with Silver Lake-led investors UAA Under Armour $18.69 / +0.08 (+0.43%) 12/04/20 Virgin Galactic unveils spacesuits developed in partnership with Under Armour 12/01/20 Under Armour announces creation and launch of Curry Brand 10/30/20 Under Armour says has line of sight to deliver slightly positive EPS in 2021 10/30/20 Under Armour to sell MyFitnessPal platform to Francisco Partners in $345M deal UA Under Armour $16.11 / +0.135 (+0.85%) 12/04/20 Virgin Galactic unveils spacesuits developed in partnership with Under Armour 12/01/20 Under Armour announces creation and launch of Curry Brand 10/30/20 Under Armour says has line of sight to deliver slightly positive EPS in 2021 10/30/20 Under Armour to sell MyFitnessPal platform to Francisco Partners in $345M deal DYN Dyne Therapeutics $21.24 / -7.65 (-26.48%) 01/10/21 Dyne Therapeutics announced new preclinical data from DM1 program 09/28/20 Citadel Advisors takes 6.5% passive stake in Dyne Therapeutics INMB INmune Bio $20.45 / -4.64 (-18.49%) 08:34 Today INmune Bio jumps 37% to $34.50 after disclosing XPro1595 data in AD 07:06 Today INmune Bio says XPro1595 found to decrease nueroinflammation biomarkers 01/13/21 INmune Bio to host KOL webinar on Phase 1b trial of XPro1595 11/09/20 INmune Bio doses first patient in Phase 2 trial of Quellor UAL TRV LLY ABCL CTVA CLGX CSGP DBD TAL UAA UA DYN INMB UAL United Airlines $42.59 / -2.59 (-5.73%) 01/14/21 Susquehanna United Airlines price target raised to $40 from $38 at Susquehanna 01/11/21 Cowen United Airlines upgraded to Outperform from Market Perform at Cowen 01/08/21 Fly Intel: Top five analyst downgrades 01/08/21 BofA United Airlines downgraded to Underperform from Neutral at BofA TRV Travelers $148.81 / +3.73 (+2.57%) 01/04/21 JPMorgan Travelers price target raised to $136 from $129 at JPMorgan 11/27/20 MKM Partners Travelers price target raised to $160 from $140 at MKM Partners 11/17/20 Barclays Travelers initiated with an Overweight at Barclays 10/29/20 BofA Chubb upgraded to Neutral at BofA with valuation gap to Travelers narrowed LLY Eli Lilly $202.26 / +0.915 (+0.45%) 01/20/21 Citi Citi opens 'positive Catalyst Watch' on Eli Lilly into Alzheimer's data 01/19/21 Roth Capital Merus price target raised to $32 from $19 at Roth Capital 01/19/21 Fly Intel: Top five analyst upgrades 01/19/21 Mizuho Eli Lilly upgraded to Buy from Neutral at Mizuho ABCL AbCellera $50.91 / +2.68 (+5.56%) 01/05/21 Fly Intel: Top five analyst initiations 01/05/21 SVB Leerink SVB Leerink bullish on AbCellera, initiates with an Outperform 01/05/21 Berenberg AbCellera initiated with a Buy at Berenberg 01/05/21 Credit Suisse AbCellera initiated with an Outperform at Credit Suisse CTVA Corteva $41.65 / -2.02 (-4.63%) 05:12 Today Redburn Corteva downgraded to Neutral from Buy at Redburn 01/19/21 Deutsche Bank Corteva named 'Catalyst Call: Buy Idea' at Deutsche Bank 01/08/21 Deutsche Bank Corteva price target raised to $50 from $40 at Deutsche Bank 12/18/20 Susquehanna Corteva downgraded to Neutral from Positive at Susquehanna CLGX CoreLogic $76.78 / +1.07 (+1.41%) 01/06/21 Wolfe Research CoreLogic downgraded to Underperform from Peer Perform at Wolfe Research 12/01/20 Truist CoreLogic downgraded to Hold from Buy at Truist 12/01/20 Truist CoreLogic downgraded to Hold from Buy at Truist 10/28/20 Truist CoreLogic could be sold for 'meaningfully more' than $80 per share, says Truist CSGP CoStar Group $913.01 / +12.01 (+1.33%) 12/22/20 JMP Securities RealPage price target raised to $101 from $80 at JMP Securities 11/23/20 Wells Fargo CoStar Group price target raised to $990 from $915 at Wells Fargo 10/28/20 Truist CoreLogic could be sold for 'meaningfully more' than $80 per share, says Truist 10/28/20 Needham CoStar Group price target raised to $1,000 from $825 at Needham DBD Diebold $13.05 / +1.85 (+16.52%) 06:02 Today JPMorgan JPMorgan upgrades 'deep value stock' Diebold to Overweight 04:47 Today JPMorgan Diebold upgraded to Overweight from Neutral at JPMorgan 10/27/20 JPMorgan Diebold assumed with a Neutral at JPMorgan 10/27/20 JPMorgan NCR Corp. upgraded to Overweight from Neutral at JPMorgan TAL TAL Education $78.02 / +10.29 (+15.19%) 12/30/20 Credit Suisse Credit Suisse cuts TAL target to $79 on margin pressure from online competition 12/29/20 CLSA TAL Education now has 'war chest' to fight competition, says CLSA 11/25/20 Morgan Stanley OneSmart downgraded to Equal Weight on margin pressure at Morgan Stanley 10/26/20 JPMorgan TAL Education downgraded to Neutral from Overweight at JPMorgan (Friday) UAA Under Armour $18.69 / +0.08 (+0.43%) 06:21 Today Deutsche Bank Under Armour upgraded to Buy from Hold at Deutsche Bank 06:06 Today Deutsche Bank Under Armour upgraded to Buy from Hold at Deutsche Bank 01/15/21 B. Riley Securities Under Armour price target raised to $15 from $13 at B. Riley Securities 01/07/21 JPMorgan Under Armour price target raised to $19 from $17 at JPMorgan UA Under Armour $16.11 / +0.135 (+0.85%) 06:21 Today Deutsche Bank Under Armour upgraded to Buy from Hold at Deutsche Bank 01/15/21 B. Riley Securities Under Armour price target raised to $15 from $13 at B. Riley Securities 01/07/21 JPMorgan Under Armour price target raised to $19 from $17 at JPMorgan 01/04/21 Pivotal Research Under Armour upgraded to Buy from Hold at Pivotal Research DYN Dyne Therapeutics $21.24 / -7.65 (-26.48%) 01/07/21 Piper Sandler Dyne Therapeutics potential beneficiary of Sarepta's SRP-9001 miss, says Piper 10/12/20 Jefferies Dyne Therapeutics initiated with a Buy at Jefferies 10/12/20 JPMorgan Dyne Therapeutics initiated with an Overweight at JPMorgan 10/12/20 Stifel Dyne Therapeutics initiated with a Buy at Stifel INMB INmune Bio $20.45 / -4.64 (-18.49%) 09/01/20 BTIG INmune Bio initiated with a Buy at BTIG 07/14/20 Roth Capital INmune Bio price target raised to $26 from $13 at Roth Capital 03/12/20 H.C. Wainwright INmune Bio price target lowered to $8 from $11 at H.C. Wainwright 03/11/20 Roth Capital INmune makes progress in all programs, novel COVID-19 approach,says Roth Capital UAL TRV LLY CTVA CLGX CSGP DBD TAL UAA UA DYN INMB UAL United Airlines $42.59 / -2.59 (-5.73%) 01/20/21 United Airlines ended 2020 with $19.7B in available liquidity 01/20/21 United sees Q1 operating revenue down 65%-70%, consensus $4.06B 01/20/21 United Airlines reports Q4 adjusted EPS ($7.00), consensus ($6.60) 01/20/21 Notable companies reporting after market close TRV Travelers $148.81 / +3.73 (+2.57%) 06:57 Today Travelers reports Q4 core EPS $4.91, consensus $3.18 10/20/20 Travelers reports Q3 core EPS $3.12, consensus $3.00 07/23/20 Travelers reports Q2 core EPS (20c), consensus (20c) 07/23/20 Travelers reports Q2 core EPS (20c), consensus (20c) LLY Eli Lilly $202.26 / +0.915 (+0.45%) 12/15/20 Eli Lilly sees FY21 EPS $7.75-$8.40, consensus $8.07 12/15/20 Eli Lilly raises FY20 EPS view to $7.45-$7.65 from $7.20-$7.40, consensus $7.32 12/02/20 Eli Lilly says updated purchase of LY-CoV555 to boost FY20 EPS view by 25c 10/27/20 Eli Lilly backs FY20 adj. EPS view $7.20-$7.40, consensus $7.28 CTVA Corteva $41.65 / -2.02 (-4.63%) 11/04/20 Corteva backs FY20 operating EPS view $1.25-$1.45, consensus $1.38 11/04/20 Corteva reports Q3 adjusted EPS (39c), consensus (42c) 11/04/20 Notable companies reporting after market close 08/05/20 Corteva sees FY20 operating EPS $1.25-$1.45, consensus $1.40 CLGX CoreLogic $76.78 / +1.07 (+1.41%) 12/11/20 CoreLogic raises FY21 adjusted EPS view to $4.40-$4.65 from $4.00-$4.20 12/11/20 CoreLogic raises FY20 adjusted EPS view to $4.15-$4.25 from $3.65 10/22/20 CoreLogic sees FY20 results at upper end of guidance range 10/22/20 CoreLogic reports Q3 EPS $1.21, consensus $1.24 CSGP CoStar Group $913.01 / +12.01 (+1.33%) 10/27/20 CoStar Group sees FY20 EPS $9.39-$9.49, consensus $9.36 10/27/20 CoStar Group sees Q4 EPS $2.34-$2.44, consensus $2.51 10/27/20 CoStar Group reports Q3 EPS $2.26, consensus $2.07 07/28/20 CoStar Group sees FY20 adjusted EPS $9.22-$9.42, consensus $9.11 DBD Diebold $13.05 / +1.85 (+16.52%) 10/28/20 Diebold raises 2020 revenue view to $3.85B from $3.7B-$3.9B, consensus $3.83B 10/28/20 Diebold reports Q3 non-GAAP EPS 28c, consensus 27c 07/30/20 Diebold sees 2020 revenue $3.7B-$3.9B, consensus $3.79B 07/30/20 Diebold reports Q2 non-GAAP EPS 38c, consensus 1c TAL TAL Education $78.02 / +10.29 (+15.19%) 05:21 Today TAL Education sees Q4 revenue $1.18B-$1.2B, consensus $1.17B 05:19 Today TAL Education reports Q3 EPS 2c, consensus 7c 10/22/20 TAL Education sees Q3 revenue $1.06B-$1.09B, consensus $1.14B 10/22/20 TAL Education reports Q2 EPS 8c, consensus 12c UAA Under Armour $18.69 / +0.08 (+0.43%) 10/30/20 Under Armour sees FY20 adj. EPS (49c)-(47c), consensus (72c) 10/30/20 Under Armour sees Q4 revenue down low-teen percentage rate, consensus $1.12B 10/30/20 Under Armour reports Q3 adj. EPS 26c, consensus 3c 10/29/20 Notable companies reporting before tomorrow's open UA Under Armour $16.11 / +0.135 (+0.85%) 10/30/20 Under Armour sees FY20 adj. EPS (49c)-(47c), consensus (72c) 10/30/20 Under Armour sees Q4 revenue down low-teen percentage rate, consensus $1.12B 10/30/20 Under Armour reports Q3 adj. EPS 26c, consensus 3c 10/29/20 Notable companies reporting before tomorrow's open DYN Dyne Therapeutics $21.24 / -7.65 (-26.48%) 11/05/20 Dyne Therapeutics reports Q3 EPS ($2.01), consensus (87c) INMB INmune Bio $20.45 / -4.64 (-18.49%) 11/05/20 INmune Bio reports Q3 EPS (36c), consensus (17c) 21 Jan 11 Dec 17 Sep 16 Jul 21 May 22 Apr UAL TRV LLY CTVA CLGX CSGP TAL UAA UA UAL United Airlines $42.59 / -2.59 (-5.73%) 01/18/21 Biden to block Trump's plan to lift COVID travel restrictions, Reuters reports 01/18/21 Trump lifting COVID travel restrictions on Europe/Brazil, Reuters reports 01/15/21 U.K. tightens borders to prevent arrival of new COVID strains, Reuters says 01/14/21 Delta, United, Alaska prohibit guns in checked bags for D.C. flights, AP says TRV Travelers $148.81 / +3.73 (+2.57%) 01/20/21 Notable companies reporting before tomorrow's open 01/20/21 Notable companies reporting before tomorrow's open LLY Eli Lilly $202.26 / +0.915 (+0.45%) 12/30/20 Fresenius to administer Lilly, Regeneron COVID antibody drugs, Reuters says 12/23/20 Judge rules against White House drug pricing rule, Reuters says 11/23/20 EU seeks easier access to generic medicines, Reuters says 11/20/20 Trump to release new rules aimed at lowering drug prices, WSJ reports CTVA Corteva $41.65 / -2.02 (-4.63%) 07:15 Today Starboard wants to take control of Corteva's board, replace CEO, WSJ reports 11/19/20 Corteva board backs CEO amid pressure from Starboard, Reuters says 10/09/20 Starboard makes new bets on Corteva, ON Semiconductor, Reuters reports CLGX CoreLogic $76.78 / +1.07 (+1.41%) 15:01 Today CoStar, Warburg group final bidders in running for CoreLogic, Bloomberg says 14:43 Today CoStar, Warburg group final bidders in running for CoreLogic, Bloomberg says 12/01/20 CoreLogic interest seen being 'strong,' CTFN reports 12/01/20 CTFN publishes report on CoreLogic auction plans CSGP CoStar Group $913.01 / +12.01 (+1.33%) 15:01 Today CoStar, Warburg group final bidders in running for CoreLogic, Bloomberg says 14:43 Today CoStar, Warburg group final bidders in running for CoreLogic, Bloomberg says 12/29/20 Rentpath terminates deal to be acquired by CoStar Group, Bloomberg says 11/22/20 CoStar in advanced talks to acquire Homesnap for $250M, WSJ reports TAL TAL Education $78.02 / +10.29 (+15.19%) 08/07/20 Citon says authorities given info to end GSX Techedu 'charade' UAA Under Armour $18.69 / +0.08 (+0.43%) 12/14/20 Under Armour sued over 'infrared' claims about workout wear, Bloomberg reports 12/01/20 Under Armour, NBA's Steph Curry to launch 'Curry Brand,' NY Post reports 10/22/20 Short-seller GlassHouse Research sees 51% downside for Columbia Sportswear 08/27/20 Under Armour sued by UCLA for pulling out of apparel deal, LA Times reports UA Under Armour $16.11 / +0.135 (+0.85%) 12/14/20 Under Armour sued over 'infrared' claims about workout wear, Bloomberg reports 12/01/20 Under Armour, NBA's Steph Curry to launch 'Curry Brand,' NY Post reports 10/22/20 Short-seller GlassHouse Research sees 51% downside for Columbia Sportswear 08/27/20 Under Armour sued by UCLA for pulling out of apparel deal, LA Times reports UAL TRV LLY ABCL CLGX CSGP DBD TAL UAA UA DYN INMB UAL United Airlines $42.59 / -2.59 (-5.73%) 12:14 Today Fly Intel: Wall Street's top stories at midday 01/20/21 Fly Intel: After-Hours Movers 12/22/20 Fly Intel: Pre-market Movers 12/11/20 Airline changes, another Tesla downgrade among today's top calls on Wall Street TRV Travelers $148.81 / +3.73 (+2.57%) 12:14 Today Fly Intel: Wall Street's top stories at midday 08:58 Today Fly Intel: Pre-market Movers 10/20/20 Fly Intel: Wall Street's top stories for Tuesday 10/20/20 Fly Intel: Wall Street's top stories at midday LLY Eli Lilly $202.26 / +0.915 (+0.45%) 12:14 Today Fly Intel: Wall Street's top stories at midday 01/11/21 Fly Intel: Wall Street's top stories for Monday 01/11/21 Fly Intel: Wall Street's top stories at midday 01/11/21 Eli Lilly and Alzheimer's research peers jump after study meets endpoint ABCL AbCellera $50.91 / +2.68 (+5.56%) 12:14 Today Fly Intel: Wall Street's top stories at midday 12/28/20 Fly Intel: After-Hours Movers 12/13/20 Opening Day: Airbnb shares double in IPO, DoorDash soars in debut CLGX CoreLogic $76.78 / +1.07 (+1.41%) 10/28/20 Fly Intel: Wall Street's top stories for Wednesday 10/28/20 Fly Intel: Wall Street's top stories at midday CSGP CoStar Group $913.01 / +12.01 (+1.33%) 10/28/20 Fly Intel: Wall Street's top stories for Wednesday 10/28/20 Fly Intel: Wall Street's top stories at midday DBD Diebold $13.05 / +1.85 (+16.52%) 12:14 Today Fly Intel: Wall Street's top stories at midday TAL TAL Education $78.02 / +10.29 (+15.19%) 12:14 Today Fly Intel: Wall Street's top stories at midday UAA Under Armour $18.69 / +0.08 (+0.43%) 12:14 Today Fly Intel: Wall Street's top stories at midday 11:31 Today Under Armour rises as Deutsche Bank says buy on turnaround progress 11/18/20 Tesla, Boeing upgrades among today's top calls on Wall Street 11/17/20 American initiation, Moderna downgrade among today's top calls on Wall Street UA Under Armour $16.11 / +0.135 (+0.85%) 12:14 Today Fly Intel: Wall Street's top stories at midday 11:31 Today Under Armour rises as Deutsche Bank says buy on turnaround progress 11/18/20 Tesla, Boeing upgrades among today's top calls on Wall Street 11/17/20 American initiation, Moderna downgrade among today's top calls on Wall Street DYN Dyne Therapeutics $21.24 / -7.65 (-26.48%) 12:14 Today Fly Intel: Wall Street's top stories at midday 09/28/20 Fly Intel: After-Hours Movers 09/20/20 Opening Day: Snowflake shares double in biggest software IPO ever INMB INmune Bio $20.45 / -4.64 (-18.49%) 12:14 Today Fly Intel: Wall Street's top stories at midday 08:58 Today Fly Intel: Pre-market Movers 01/26/21 Pharmacovigilance & Risk Management Strategies Virtual Conference 01/28/21 IASLC Virtual World Conference on Lung Cancer 03/15/21 33rd Annual Roth Virtual Conference 08:00 Today TAL Education - TAL 09:00 Today Travelers - TRV 10:30 Today United Airlines - UAL 01/29/21 Eli Lilly - LLY 02/04/21 Corteva - CTVA UAL TRV LLY TAL UAA UA UAL United Airlines $42.59 / -2.59 (-5.73%) 01/20/21 United Continental options imply 6.4% move in share price post-earnings 12/16/20 United Continental call volume above normal and directionally bullish 12/10/20 Unusual call flow in option market yesterday 12/09/20 Airlines put buyers prepare for turbulence TRV Travelers $148.81 / +3.73 (+2.57%) 09:55 Today Early notable gainers among liquid option names on January 21st LLY Eli Lilly $202.26 / +0.915 (+0.45%) 01/15/21 Eli Lilly call volume above normal and directionally bullish 01/13/21 Early notable gainers among liquid option names on January 13th 01/11/21 Early notable gainers among liquid option names on January 11th 12/09/20 Early notable gainers among liquid option names on December 9th TAL TAL Education $78.02 / +10.29 (+15.19%) 09/03/20 Tal Education Group put volume heavy and directionally bearish UAA Under Armour $18.69 / +0.08 (+0.43%) 09:40 Today Unusually active option classes on open January 21st 07:35 Today Unusual call flow in option market yesterday 01/20/21 Bull tries on $2M worth of Under Armour March 20 calls 12/08/20 Unusual call flow in option market yesterday UA Under Armour $16.11 / +0.135 (+0.85%) 12/01/20 Under Armour call volume above normal and directionally bullish 11/16/20 Under Armour call volume above normal and directionally bullish 11/12/20 Under Armour call volume above normal and directionally bullish 10/30/20 Early notable gainers among liquid option names on October 30th
Hot Stocks	Ford to replace Takata airbag inflators in certain models at cost of $610M » 16:40 01/21/21 01/21 16:40 01/21/21 16:40 F Ford $11.53 / +0.665 (+6.12%) The company states in an… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options F Ford $11.53 / +0.665 (+6.12%) 01/19/21 EU passenger car registrations down 3.3% in December 01/11/21 Ford to stop manufacturing in Brazil, sees pre-tax special item charges of $4.1B 01/11/21 Ford to stop manufacturing in Brazil, sees pre-tax special item charges of $4.1B 01/06/21 Ford reports Q4 U.S. sales down 9.8% y/y to 542,749 vehicles F Ford $11.53 / +0.665 (+6.12%) 01/20/21 Deutsche Bank Ford price target raised to $11 from $9 at Deutsche Bank 01/20/21 Deutsche Bank Ford named 'Catalyst Call: Buy Idea' at Deutsche Bank 01/05/21 Benchmark GM, Roku, Marcus among Benchmark's Best Ideas for first half of 2021 12/23/20 Morgan Stanley Apple's potential EV entry represents 'new Tesla bear case,' says Morgan Stanley F Ford $11.53 / +0.665 (+6.12%) 10/28/20 Ford sees temporarily lower F-150 wholesale shipments in Q4 10/28/20 Ford reports Q3 adjusted EBIT $3.6B 10/28/20 Ford reports Q3 adjusted EPS 65c, consensus 16c 10/28/20 Notable companies reporting after market close F Ford $11.53 / +0.665 (+6.12%) 01/19/21 Amazon and Ford backed EV Truck-maker Rivian raises another $2.65B, WSJ says 01/08/21 Ford to idle Kentucky plant, blames microchip shortage, Detroit News reports 01/05/21 Rivian close to raising funds at $25B valuation, Bloomberg says 01/05/21 Rivian close to raising funds at $25B valuation, Bloomberg says F Ford $11.53 / +0.665 (+6.12%) 01/11/21 Fly Intel: Wall Street's top stories for Monday 12/26/20 Charged: Apple's potential EV entry seen as 'Tesla bear case' 12/22/20 Apple rises as Wall Street digests report of self-driving car plans 12/07/20 Fly Intel: Wall Street's top stories for Monday 02/04/21 Ford - F F Ford $11.53 / +0.665 (+6.12%) 11:30 Today Ford call volume off to the races as shares and implied volatility surge 08:55 Today Notable open interest changes for January 21st 01/20/21 Ford call volume above normal and directionally bullish 01/20/21 Early notable gainers among liquid option names on January 20th
Hot Stocks	BlackBerry CFO Steve Rai sells almost $430K in company shares » 16:39 01/21/21 01/21 16:39 01/21/21 16:39 BB BlackBerry $12.83 / +0.05 (+0.39%) BlackBerry CFO Steve Rai… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options BB BlackBerry $12.83 / +0.05 (+0.39%) 01/19/21 BlackBerry rises 17.4% 01/15/21 BlackBerry rises 20.8% 01/15/21 BlackBerry rises 22.7% 12/18/20 BlackBerry falls -13.1% BB BlackBerry $12.83 / +0.05 (+0.39%) 12/18/20 TD Securities BlackBerry price target raised to $8.50 from $5.50 at TD Securities 12/15/20 RBC Capital BlackBerry price target raised to $7.50 from $5 at RBC Capital 12/15/20 RBC Capital BlackBerry price target raised to $7.50 from $5.00 at RBC Capital 12/01/20 TD Securities BlackBerry jump on AWS pact looks like overreaction, says TD Securities BB BlackBerry $12.83 / +0.05 (+0.39%) 12/17/20 BlackBerry reports Q3 adjusted EPS 2c, consensus (1c) 09/24/20 BlackBerry reports Q2 non-GAAP EPS 11c, consensus 2c BB BlackBerry $12.83 / +0.05 (+0.39%) 01/15/21 BlackBerry reports settlement with Facebook over patents, Bloomberg says BB BlackBerry $12.83 / +0.05 (+0.39%) 01/20/21 #SocialStocks: Facebook could be in focus under new administration 12/17/20 Fly Intel: After-Hours Movers 12/01/20 Fly Intel: Wall Street's top stories for Tuesday 12/01/20 Fly Intel: Wall Street's top stories at midday BB BlackBerry $12.83 / +0.05 (+0.39%) 01/20/21 Notable open interest changes for January 20th 01/15/21 Unusual call flow in option market yesterday 01/14/21 BlackBerry call volume above normal and directionally bullish 01/11/21 Unusually active option classes on open January 11th

Earnings	Metropolitan Bank reports Q4 EPS $1.39, consensus $1.16 » 16:38 01/21/21 01/21 16:38 01/21/21 16:38 MCB Metropolitan Bank $38.08 / -0.98 (-2.51%) Q4 provision for loan… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings MCB Metropolitan Bank $38.08 / -0.98 (-2.51%) 08/07/20 Metropolitan Bank appoints Greg Sigrist as CFO 08/05/20 Metropolitan Bank names Dixiana Berrios COO MCB Metropolitan Bank $38.08 / -0.98 (-2.51%) 12/15/20 JPMorgan Metropolitan Bank price target raised to $50 from $36 at JPMorgan 07/22/20 Keefe Bruyette Metropolitan Bank price target raised to $40 from $32 at Keefe Bruyette MCB Metropolitan Bank $38.08 / -0.98 (-2.51%) 10/21/20 Metropolitan Bank reports Q3 EPS $1.27, consensus 97c 07/22/20 Metropolitan Bank reports Q2 EPS $1.29, two estimates 79c
Syndicate	Akero Therapeutics files to sell 99.25M shares of common stock for holders 16:37 01/21/21 01/21 16:37 01/21/21 16:37 AKRO Akero Therapeutics $29.90 / -0.35 (-1.16%) ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly AKRO Akero Therapeutics $29.90 / -0.35 (-1.16%) 11/13/20 Akero announces presentation of additional BALANCED study data analysis 10/16/20 Akero Therapeutics receives EMA PRIME designation for efruxifermin in NASH 09/30/20 Akero Therapeutics completes enrollment of cirrhotic patients in NASH study 09/24/20 Akero Therapeutics greenlit to continue efruxifermin Phase 2b/3 trial in NASH AKRO Akero Therapeutics $29.90 / -0.35 (-1.16%) 11/13/20 H.C. Wainwright Akero Therapeutics price target raised to $64 from $62 at H.C. Wainwright 10/16/20 H.C. Wainwright Akero's PRIME designation an 'important recognition,' says H.C. Wainwright 09/10/20 Morgan Stanley Akero Therapeutics initiated with an Overweight at Morgan Stanley 08/31/20 B. Riley FBR NGM released 'overwhelmingly positive' NASH update, says B. Riley FBR AKRO Akero Therapeutics $29.90 / -0.35 (-1.16%) 11/12/20 Akero Therapeutics reports Q3 EPS (63c), consensus (65c) 08/12/20 Akero Therapeutics reports Q2 EPS (57c), consensus (62c) 08 Jul AKRO Akero Therapeutics $29.90 / -0.35 (-1.16%) 09/30/20 Before the Move: Watch Novo Nordisk, Bristol into AASLD abstract publication
Syndicate	Akero Therapeutics files to sell 1.1M shares of common stock 16:36 01/21/21 01/21 16:36 01/21/21 16:36 AKRO Akero Therapeutics $29.90 / -0.35 (-1.16%) ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly AKRO Akero Therapeutics $29.90 / -0.35 (-1.16%) 11/13/20 Akero announces presentation of additional BALANCED study data analysis 10/16/20 Akero Therapeutics receives EMA PRIME designation for efruxifermin in NASH 09/30/20 Akero Therapeutics completes enrollment of cirrhotic patients in NASH study 09/24/20 Akero Therapeutics greenlit to continue efruxifermin Phase 2b/3 trial in NASH AKRO Akero Therapeutics $29.90 / -0.35 (-1.16%) 11/13/20 H.C. Wainwright Akero Therapeutics price target raised to $64 from $62 at H.C. Wainwright 10/16/20 H.C. Wainwright Akero's PRIME designation an 'important recognition,' says H.C. Wainwright 09/10/20 Morgan Stanley Akero Therapeutics initiated with an Overweight at Morgan Stanley 08/31/20 B. Riley FBR NGM released 'overwhelmingly positive' NASH update, says B. Riley FBR AKRO Akero Therapeutics $29.90 / -0.35 (-1.16%) 11/12/20 Akero Therapeutics reports Q3 EPS (63c), consensus (65c) 08/12/20 Akero Therapeutics reports Q2 EPS (57c), consensus (62c) 08 Jul AKRO Akero Therapeutics $29.90 / -0.35 (-1.16%) 09/30/20 Before the Move: Watch Novo Nordisk, Bristol into AASLD abstract publication
Hot Stocks	CarGurus CEO Langley Steinert shifts to chairman role, Jason Trevisan succeeds » 16:35 01/21/21 01/21 16:35 01/21/21 16:35 CARG CarGurus $31.86 / -0.07 (-0.22%) CarGurus announced that… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly CARG CarGurus $31.86 / -0.07 (-0.22%) 12/10/20 CarGurus to acquire 51% stake in CarOffer for $275M 11/20/20 Ford to launch used vehicle platform Ford Blue Advantage 08/25/20 CarGurus announces Global Lending Services as lending partner CARG CarGurus $31.86 / -0.07 (-0.22%) 12/14/20 BTIG CarGurus price target raised to $34 from $28 at BTIG 12/11/20 DA Davidson CarGurus found 'compelling' asset in CarOffer, says DA Davidson 12/10/20 Benchmark CarGurus' deal for CarOffer increases Benchmark's 'optimistic view' 12/04/20 Jefferies CarGurus initiated with a Hold at Jefferies CARG CarGurus $31.86 / -0.07 (-0.22%) 11/05/20 CarGurus sees FY20 EPS $1.01-$1.03, consensus 69c 11/05/20 CarGurus sees Q4 EPS 26c-28c, consensus 9c 11/05/20 CarGurus reports Q3 EPS 37c, consensus 22c 08/06/20 CarGurus sees FY20 EPS 66c-69c, consensus 44c CARG CarGurus $31.86 / -0.07 (-0.22%) 11/05/20 Fly Intel: After-Hours Movers 08/17/20 Fly Insider: Red Rock, CarGurus among week's notable insider trades 07/28/20 Tesla downgrade, Shopify upgrade among today's top calls on Wall Street
Initiation	Fisker initiated with a Market Perform at Raymond James » 16:33 01/21/21 01/21 16:33 01/21/21 16:33 FSR Fisker $15.00 / +0.235 (+1.59%) Raymond James analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research On The Fly Events Options FSR Fisker $15.00 / +0.235 (+1.59%) 01/04/21 Magna to collaborate with Fisker on Advanced Driver Assistance System 12/17/20 Fisker jumps with paid Ocean SUV reservations topping 10,400 globally 12/17/20 Fisker, Magna enter definitive platform, manufacturing agreements 12/10/20 Fisker falls -7.4% FSR Fisker $15.00 / +0.235 (+1.59%) 01/04/21 Fly Intel: Top five analyst initiations 01/04/21 Vertical Group Fisker initiated with a Buy at Vertical Group 12/30/20 Cowen Fisker estimates reduced following company guidance, says Cowen 12/11/20 Fly Intel: Top five analyst initiations FSR Fisker $15.00 / +0.235 (+1.59%) 11/25/20 Fly Intel: Wall Street's top stories for Wednesday 11/25/20 Fly Intel: Wall Street's top stories at midday 11/25/20 Ford, Gap downgrades among today's top calls on Wall Street 11/25/20 Fly Intel: Pre-market Movers 02/11/21 Technology & Internet Virtual Conference FSR Fisker $15.00 / +0.235 (+1.59%) 11:25 Today Fisker call volume above normal and directionally bullish 12/31/20 Largest borrow rate increases among liquid names 12/23/20 Fisker call volume above normal and directionally bullish 12/22/20 Largest borrow rate increases among liquid names

Earnings	People's United reports Q4 operating EPS 35c, consensus 33c » 16:32 01/21/21 01/21 16:32 01/21/21 16:32 PBCT People's United $14.15 / -0.32 (-2.21%) "We are pleased with… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events Options PBCT People's United $14.15 / -0.32 (-2.21%) 09/22/20 People's United to sell People's United Insurance Agency to AssuredPartners PBCT People's United $14.15 / -0.32 (-2.21%) 01/07/21 Jefferies People's United upgraded to Buy with $16 price target at Jefferies 01/07/21 Jefferies People's United upgraded to Buy from Hold at Jefferies 12/17/20 Seaport Global Seaport Global rolls out coverage of Regional and Community Banks with 4 Buys 12/17/20 Seaport Global People's United initiated with a Buy at Seaport Global PBCT People's United $14.15 / -0.32 (-2.21%) 14:41 Today Notable companies reporting after market close 10/22/20 People's United reports Q3 EPS 34c, consensus 29c 10/22/20 Notable companies reporting after market close 07/23/20 People's United reports Q2 operating EPS 24c, consensus 22c 17:00 Today People's United - PBCT PBCT People's United $14.15 / -0.32 (-2.21%) 07/24/20 Early notable gainers among liquid option names on July 24th
Initiation	Noah Holdings initiated with an Overweight at Morgan Stanley » 16:31 01/21/21 01/21 16:31 01/21/21 16:31 NOAH Noah Holdings $49.27 / +0.07 (+0.14%) Morgan Stanley analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research On The Fly Options NOAH Noah Holdings $49.27 / +0.07 (+0.14%) 11/30/20 Noah Holdings announces $100M share repurchase program NOAH Noah Holdings $49.27 / +0.07 (+0.14%) 16:22 Today Morgan Stanley Noah Holdings initiated with an Overweight at Morgan Stanley 01/07/21 JPMorgan Noah Holdings downgraded to Neutral from Overweight at JPMorgan 07/10/20 Citi Citi boosts Noah Holdings target, opens 'positive catalyst watch' 03/30/20 Citi Noah Holdings upgraded to Buy from Neutral at Citi NOAH Noah Holdings $49.27 / +0.07 (+0.14%) 11/30/20 Fly Intel: After-Hours Movers NOAH Noah Holdings $49.27 / +0.07 (+0.14%) 11/30/20 Noah Holdings options imply 10.3% move in share price post-earnings 08/24/20 Noah Holdings options imply 3.1% move in share price post-earnings
Earnings	BancFirst reports Q4 EPS $1.06, consensus 74c » 16:31 01/21/21 01/21 16:31 01/21/21 16:31 BANF BancFirst $62.90 / -1.37 (-2.13%) The provision for credit… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Earnings Options BANF BancFirst $62.90 / -1.37 (-2.13%) 10/01/20 BancFirst to sell $20M in loans, $38M in deposits to AmeriState Bank 08/27/20 BancFirst raises dividend on common stock to 34c from 32c per share 08/03/20 BancFirst to replace Sunrun in S&P 600 at open on 8/3 07/28/20 BancFirst to replace Sunrun in S&P 600 at open on 8/3 BANF BancFirst $62.90 / -1.37 (-2.13%) 10/15/20 BancFirst reports Q3 EPS 63c, consensus 76c BANF BancFirst $62.90 / -1.37 (-2.13%) 07/22/20 Two new option listings on July 22nd
Hot Stocks	National Bank raises quarterly dividend 5% to 21c from 20c per share » 16:30 01/21/21 01/21 16:30 01/21/21 16:30 NBHC National Bank $35.49 / -0.52 (-1.44%) The dividend will be… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events NBHC National Bank $35.49 / -0.52 (-1.44%) 08/05/20 National Bank announces 20c quarterly dividend NBHC National Bank $35.49 / -0.52 (-1.44%) 11/20/20 Fly Intel: Top five analyst downgrades 11/20/20 DA Davidson National Bank downgraded to Neutral from Buy at DA Davidson 11/20/20 DA Davidson National Bank downgraded to Neutral from Buy at DA Davidson 04/23/20 Stephens National Bank downgraded to Equal Weight from Overweight at Stephens NBHC National Bank $35.49 / -0.52 (-1.44%) 16:12 Today National Bank reports Q4 EPS 87c, consensus 66c 10/20/20 National Bank reports Q3 EPS 90c, consensus 58c 01/22/21 National Bank - NBHC
Syndicate	Aurora Cannabis announces $125M bought deal financing » 16:30 01/21/21 01/21 16:30 01/21/21 16:30 ACB Aurora Cannabis $11.17 / -0.39 (-3.37%) Aurora Cannabis announced… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Options ACB Aurora Cannabis $11.17 / -0.39 (-3.37%) 01/14/21 Aurora Cannabis announces Canadian retail sales deal with Great North 01/06/21 Aurora Cannabis rises 13.7% 01/06/21 Aurora Cannabis rises 13.8% 12/16/20 Aurora Cannabis provides business update, closing Aurora Sun facility ACB Aurora Cannabis $11.17 / -0.39 (-3.37%) 01/06/21 BMO Capital Federal cannabis reform in U.S. likely to take time, says BMO Capital 12/17/20 BMO Capital Aurora Cannabis downgraded to Underperform from Market Perform at BMO Capital 12/04/20 Alliance Global Partners Alliance Global sees low odds of MORE Act passing this congressional session 12/02/20 Alliance Global Partners Alliance Global Partners sees UN cannabis reclassification helping legalization ACB Aurora Cannabis $11.17 / -0.39 (-3.37%) 11/09/20 Aurora Cannabis reports Q1 revenue C$67.8M vs. C$67.5M in Q4 10/30/20 Aurora Cannabis sees Q1 revenue at high end of $60M-$64M previous guidance 09/22/20 Aurora Cannabis sees Q1 revenue $60M-$64M vs. $67.5M in Q4 09/22/20 Aurora Cannabis reports Q4 revenue $72.1M, a 5% decline from last quarter 11 Nov ACB Aurora Cannabis $11.17 / -0.39 (-3.37%) 01/08/21 Deal to legalize marijuana in New Jersey suddenly collapses, NJ.com says 01/05/21 NY lawmakers file marijuana bill for 2021 session, Marijuana Moment says 12/30/20 Mexico on track to become largest legal cannabis market, WSJ reports 12/17/20 NJ lawmakers pass legal weed bill, now goes to Gov. Murphy, NJ.com reports ACB Aurora Cannabis $11.17 / -0.39 (-3.37%) 11:31 Today Rising High: An exclusive talk with emulsion provider SoRSE Technology 01/14/21 Rising High: An exclusive talk with cannabinoid market research firm BDSA 01/07/21 Rising High: WeedMD consolidates medical distribution activities 12/31/20 Rising High: Canopy Rivers sells Canapar stake, Stem closes Driven deal ACB Aurora Cannabis $11.17 / -0.39 (-3.37%) 01/13/21 Aurora Cannabis call volume above normal and directionally bullish 01/11/21 Aurora Cannabis call volume above normal and directionally bullish 11/30/20 Aurora Cannabis call buyer realizes 57% same-day gains 11/27/20 Largest borrow rate increases among liquid names

Events

Earnings calls, analyst events, roadshows and more

SIVB
Today at 18:00

SVB Financial - SIVB Conference Calls
AUPH
Tomorrow at 00:00

PDUFA Date for Voclosporin Government Event
MNGPF
Tomorrow at 00:00

Quant & Derivatives Virtual Conference Conferences

Virtual Conference
Tomorrow at 00:00

2021 VESS Annual Winter Meeting Conferences

Virtual Meeting
Tomorrow at 00:00

Western Institutional Investor Virtual Conference Conferences

Virtual Conference
Tomorrow at 00:00

Aesthetics Tech Virtual Summit 2021 Conferences

Virtual Summit
Tomorrow at 00:00

Early Cancer Screening, Diagnostics Reimbursement and Genomic Tools KOL Day Conferences

Virtual Meeting
AOUT
Tomorrow at 00:00

Virtual Outdoor Day Conferences

Virtual Event
TA
Tomorrow at 00:00

TravelCenters Firm Sponsored Meetings

Virtual Meeting
DM
Tomorrow at 00:00

Desktop Metal Firm Sponsored Meetings

Virtual Meeting

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	No deals
Tues	BDGE X BDGE Bridge Bancorp Block Trade Managers: Morgan Stanley Priced at: $25.50 700K Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial TCRR X TCRR TCR2 Therapeutics Secondary Managers: Goldman Sachs, Jefferies, Piper Sandler & BMO Capital Priced at: $30.50 4.59M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ACRS X ACRS Aclaris Therapeutics Spot Secondary Managers: Cantor Fitzgerald & William Blair, H.C. Wainwright Priced at: $17.50 5.484M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ACRX X ACRX AcelRx Spot Secondary Managers: Cantor Fitzgerald Priced at: $1.90 14.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial BLRX X BLRX BioLineRx Spot Secondary Managers: H.C. Wainwright Priced at: $2.40 12.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial BNGO X BNGO Bionano Genomics Spot Secondary Managers: Oppenheimer, BTIG, Ladenburg, Maxim Priced at: $6.00 33.333M Shares DSS X DSS Document Security Spot Secondary Managers: Aegis Priced at: $3.60 6.67M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial FULC X FULC Fulcrum Therapeutics Spot Secondary Managers: SVB Leerink, Piper Sandler & Credit Suisse Priced at: $11.00 4M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial LAC X LAC Lithium Americas Spot Secondary Managers: Canaccord, Deutsche Bank, Evercore ISI, Stifel Priced at: $22.00 15.9M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial PERI X PERI Perion Network Spot Secondary Managers: Oppenheimer, Stifel, Roth Capital, LAKE Priced at: $11.50 4.99M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SYRS X SYRS Syros Pharmaceuticals Spot Secondary Managers: Cowen & Piper Sandler Priced at: $14.00 5.4M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Wed	DFH X DFH Dream Finders Homes IPO Managers: BofA, RBC Capital & BTIG, Builder Advisor, Zelman, TCB Capital, Wedbush Priced at: $13.00 9.6M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial MYTE X MYTE Mytheresa IPO Managers: Morgan Stanley & JPMorgan, Credit Suisse, UBS, Jefferies, Cowen Priced at: $26.00 15.647M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ATHA X ATHA Athira Pharma Secondary Managers: Goldman Sachs, Jefferies, Stifel & JMP Securities Priced at: $22.50 4M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CDNA X CDNA CareDx Secondary Managers: Goldman Sachs & Jefferies, Raymond James, BTIG, Craig-Hallum, H.C. Wainwright Priced at: $91.00 1.923M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CMRX X CMRX Chimerix Secondary Managers: Jefferies & Cowen, H.C. Wainwright, JonesTrading Priced at: $8.50 11.765M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CTMX X CTMX CytomX Therapeutics Secondary Managers: JPMorgan, Cowen & Piper Sandler Priced at: $7.00 14.286M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial DYN X DYN Dyne Therapeutics Secondary Managers: JPMorgan, Jefferies, Piper Sandler & Stifel Priced at: $28.00 6M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial EDIT X EDIT Editas Medicine Secondary Managers: JPMorgan & Morgan Stanley, Cowen, Credit Suisse Priced at: $66.00 3.5M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial MRUS X MRUS Merus Secondary Managers: Jefferies & SVB Leerink Priced at: $24.75 4.85M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CYRX X CYRX Cryoport Spot Secondary Managers: Morgan Stanley, Jefferies, SVB Leerink & UBS Priced at: $66.00 3.788M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial INO X INO Inovio Spot Secondary Managers: BofA, Jefferies & Cantor Fitzgerald, Oppenheimer Priced at: $8.50 2.655M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ONCS X ONCS OncoSec Spot Secondary Managers: BTIG Priced at: $5.45 7.71M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ORC X ORC Orchid Island Capital Spot Secondary Managers: JPMorgan Priced at: $5.30 7.6M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Thurs	No deals
Fri	No deals

Mon	No deals
Tues	No deals
Wed	No deals
Thurs	PAX X PAX Patria IPO Managers: JPMorgan, BofA & Credit Suisse, Goldman Sachs, Bradesco BBI, BTG Pactual, ITAU, Keefe Bruyette, Santander, XP $14.00-16.00 26.65M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial RLX X RLX RLX Technology IPO Managers: Citi, China Renaissance $8.00-10.00 116.5M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial AZEK X AZEK Azek Secondary Managers: Barclays, BofA, Goldman Sachs & Jefferies $42.25 17.5M Shares CRSR X CRSR Corsair Gaming Secondary Managers: Goldman Sachs, Barclays, Credit Suisse, Macquarie, Baird, Cowen, & Stifel, Wedbush, Academy Securities $37.73 7.5M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial DCBO X DCBO Docebo Secondary Managers: Morgan Stanley, Goldman Sachs & Canaccord $70.51 3.65M Shares NVTA X NVTA Invitae Secondary Managers: JPMorgan, Morgan Stanley, Cowen & SVB Leerink $56.93 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial PASG X PASG Passage Bio Secondary Managers: JPMorgan, Goldman Sachs & Cowen, Wedbush, Chardan $29.05 7M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SI X SI Silvergate Capital Secondary Managers: Goldman Sachs, Keefe Bruyette & Canaccord, Compass Point, Craig-Hallum $66.43 Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial GSL X GSL Global Ship Lease Spot Secondary Managers: Jefferies & B. Riley Securities $13.00-14.00 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial PGEN X PGEN Precigen Spot Secondary Managers: Wells Fargo & Stifel, JMP Securities, H.C. Wainwright $7.50-8.00 VRAY X VRAY ViewRay Spot Secondary Managers: Morgan Stanley $4.75-4.95 11.5M Shares
Fri	No deals

View All Syndicate Announcements »

8-Week Bill Announcement to be released at 11:00

TODAY'S FREE FLY STORIES

Get Full Fly Access